Select therapeutic use:
Indications for Orphenadrine Citrate Extended-Release Tablets:
Painful musculoskeletal conditions.
100mg twice daily (AM and PM).
Glaucoma. Achalasia. GU or GI obstruction. Myasthenia gravis.
Coronary disease, insufficiency, or arrhythmias. Asthma (inj). Monitor blood, urine, and liver in long-term use. Pregnancy (Cat.C). Nursing mothers.
Potentiates anticholinergics, alcohol, other CNS depressants, MAOIs, antidepressants. Tremors, mental confusion with propoxyphene. Antagonizes steroids, barbiturates, phenylbutazone.
Tachycardia, transient dizziness or syncope, other anticholinergic effects (eg, weakness, increased intraocular pressure, urinary retention, blurred vision, dry mouth), GI upset.
Formerly known under the brand name Norflex.